Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells

A heterodimeric bispecific biological recombinant drug was synthesized by splicing DNA fragments from two fully humanized single-chain variable-fragment (scFV) antibody fragments forming a novel drug simultaneously recognizing the CD16 natural killer (NK) cell marker and the cancer marker epithelial...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Vallera, Daniel A., Zhang, Bin, Gleason, Michelle K., Oh, Seunguk, Weiner, Louis M., Kaufman, Dan S., McCullar, Valarie, Miller, Jeffrey S., Verneris, Michael R.
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2013
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209492/
https://ncbi.nlm.nih.gov/pubmed/23611188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2012.1329
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars